Remifentanil Versus Propofol for TCI Sedation of Patients Undergoing Gastrointestinal Endoscopic Procedures

• Status: Terminated
• Trial end date: 2010-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study was to compare remifentanil and propofol for sedation of patients during endoscopic gastrointestinal procedures.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fundación Universitaria de Ciencias de la Salud
• Collaborator: Hospital de San Jose
• Treatments: Propofol; Remifentanil

Criteria

Inclusion Criteria:

• Patient undergoing elective higher, lower or mixed gastrointestinal endoscopy at Hospital de San Jose, Bogota, between January and December 2010.

• Be between 18 and 70 years old.

• American Society of Anesthesiology Physical Status classification between 1 and 3.

• Provide written informed consent.

Exclusion Criteria:

• Patients with difficult airway indicators.

• Pregnant women.

• Patients with chronic pain.

• Chronic opioid or benzodiazepine users (>3 months).

• Allergy history to remifentanil or propofol or eggs.

• Psychoactive drug users.

• Smokers (> 5 cigarettes per day in the previous 3 months).

• Body mass index > 30.